C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma

SIMPLE SUMMARY: There is no curative treatment for mycosis fungoides and Sézary syndrome, which are the most frequent forms of cutaneous T cell lymphoma (CTCL). Short-chain ceramides like C6 Ceramide are known to induce cell death by both apoptosis and necrosis. Here, we demonstrate that C6 Ceramide...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilhelm, Raphael, Eckes, Timon, Imre, Gergely, Kippenberger, Stefan, Meissner, Markus, Thomas, Dominique, Trautmann, Sandra, Merlio, Jean-Philippe, Chevret, Edith, Kaufmann, Roland, Pfeilschifter, Josef, Koch, Alexander, Jäger, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828274/
https://www.ncbi.nlm.nih.gov/pubmed/33450826
http://dx.doi.org/10.3390/cancers13020270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828274/
https://www.ncbi.nlm.nih.gov/pubmed/33450826
http://dx.doi.org/10.3390/cancers13020270

Ejemplares similares